You appear to be using incognito/private browsing mode or an ad blocker, which may adversely affect your experience on the site. Please disable any ad blockers and view the site in non-private mode.
For in vitro diagnostic use. Others Elecsys Troponin I STAT IVD Elecsys® Troponin I STAT CPS_000527 05094798160 Troponin I STAT Elecsys cobas e 100 Elecsys Troponin I STAT 04015630939381 Reagents, kits 100 tests cobas e 411/601/602 true 05094798190 Troponin I STAT Elecsys cobas e 100 Elecsys Troponin I STAT 04015630924318 Reagents, kits 100 tests cobas e 411/601/602 true 05094798501 Elecsys Troponin I STAT en 11 FF0000000646E20E FF000000000E6C0E 05094798160 618 cobas e 411 2325 cobas e 602 619 cobas e 601 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended useImmunoassay for the in vitro quantitative determination of cardiac troponin I in human serum and plasma. This assay is intended to aid in the diagnosis of myocardial infarction.The electrochemiluminescence immunoassay “ECLIA” is intended for use on Elecsys and cobas e immunoassay analyzers. en 05094798500 Elecsys Troponin I STAT en 11 FF000000059D3C0E FF000000000ADB0E 05094798190 618 cobas e 411 2325 cobas e 602 619 cobas e 601 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended useImmunoassay for the in vitro quantitative determination of cardiac troponin I in human serum and plasma. This assay is intended to aid in the diagnosis and treatment of myocardial infarction and cardiac muscle damage. Cardiac troponin I determinations aid in the risk stratification of patients with unstable angina pectoris or non‑ST‑segment elevation acute coronary syndrome with respect to relative risk of mortality, myocardial infarction, or increased probability of ischemic events requiring urgent revascularization procedures.The electrochemiluminescence immunoassay “ECLIA” is intended for use on Elecsys and cobas e immunoassay analyzers. en